Lexaria Bioscience (LEXX) Shares Outstanding (Entity) (2011 - 2024)
Lexaria Bioscience (LEXX) reported Shares Outstanding (Entity) of 1.05 million for fiscal Q3 2024 (quarter ended May 31, 2024), up 145.5% from 429,400 a year earlier and up 27.6% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Shares Outstanding (Entity) (2011 - 2024) Analysis & Trends
For FY2023 (ended Aug 31, 2023), Lexaria Bioscience posted Shares Outstanding (Entity) of 440,938, up 11.1% from FY2022.
- Shares Outstanding (Entity) has increased for nine consecutive fiscal years, with a five-year compound annual growth rate of 21.3% (FY2018 to FY2023).
- By fiscal year, Shares Outstanding (Entity) came in at 396,733 in FY2022 (+35.5%), 292,763 in FY2021 (+46.3%), 200,078 in FY2020 (+14.3%) and 175,065 in FY2019 (+4.3%).
- The fiscal Q3 2024 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q3 2011.
- Year over year, Shares Outstanding (Entity) has now increased in each of the last five quarters, with growth averaging 48.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.0% (fiscal Q2 2023) to 145.5% (fiscal Q3 2024).
- Per Business Quant data, the three fiscal quarters before Q3 2024 came in at 825,845 (Q2 2024), 687,443 (Q1 2024) and 440,938 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.05 Mn |
| Feb 29, 2024 | 825,845.00 |
| Nov 30, 2023 | 687,443.00 |
| Aug 31, 2023 | 440,938.00 |
| May 31, 2023 | 429,400.00 |
| Feb 28, 2023 | 396,733.00 |
| Nov 30, 2022 | 396,733.00 |
| Aug 31, 2022 | 396,733.00 |
| May 31, 2022 | 396,733.00 |
| Feb 28, 2022 | 396,733.00 |
| Nov 30, 2021 | 381,780.00 |
| Aug 31, 2021 | 292,763.00 |
| May 31, 2021 | 340,289.00 |
| Feb 28, 2021 | 270,194.00 |
| Nov 30, 2020 | 200,098.00 |
| Aug 31, 2020 | 200,078.00 |
| May 31, 2020 | 199,063.00 |
| Feb 29, 2020 | 179,362.00 |
| Nov 30, 2019 | 179,117.00 |
| Aug 31, 2019 | 175,065.00 |
API Access
Lexaria Bioscience Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();